These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12088452)

  • 21. CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes.
    Min YH; Lee ST; Min DW; Kim TS; Lee CH; Lee BK; Hahn JS; Ko YW
    Yonsei Med J; 1995 Mar; 36(1):1-8. PubMed ID: 7537931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Importance of immunomorphometric evaluation of the size and number of megakaryocytes in normal and pathologic bone marrow].
    Marisavljević D; Rolović Z; Mitrović D
    Srp Arh Celok Lek; 1993; 121(3-7):57-61. PubMed ID: 7716637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
    Mangi MH; Mufti GJ
    Blood; 1992 Jan; 79(1):198-205. PubMed ID: 1370203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myelodysplastic syndromes: immunohistochemical and morphometric evaluation of proliferative activity in erythropoiesis and endoreduplicative capacity of megakaryocytes.
    Thiele J; Hoffmann I; Bertsch HP; Fischer R
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(1):33-8. PubMed ID: 8105604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections.
    Pellegrini W; Facchetti F; Marocolo D; Salvi L; Capucci A; Tironi A; Rossi G
    Histopathology; 1995 Nov; 27(5):397-405. PubMed ID: 8575729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of a xenograft model of human myelodysplastic syndromes.
    Muguruma Y; Matsushita H; Yahata T; Yumino S; Tanaka Y; Miyachi H; Ogawa Y; Kawada H; Ito M; Ando K
    Haematologica; 2011 Apr; 96(4):543-51. PubMed ID: 21193418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.
    Orazi A; Chiu R; O'Malley DP; Czader M; Allen SL; An C; Vance GH
    Mod Pathol; 2006 Dec; 19(12):1536-45. PubMed ID: 17041567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
    Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
    Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens.
    Orazi A; Albitar M; Heerema NA; Haskins S; Neiman RS
    Am J Clin Pathol; 1997 Mar; 107(3):268-74. PubMed ID: 9052376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.
    Loken MR; Chu SC; Fritschle W; Kalnoski M; Wells DA
    Cytometry B Clin Cytom; 2009 Jan; 76(1):27-36. PubMed ID: 18548614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and Clinical Studies of Patients With Increased Multinucleated Megakaryocytes in Bone Marrow as an Isolated Finding: A Diagnostic Pitfall for Myelodysplastic Syndrome.
    Zheng G; He R; Reichard KK; Peterson JF; Olteanu H; Oliveira JL; Rangan A; Chen D; Shi M
    Am J Surg Pathol; 2021 Nov; 45(11):1534-1540. PubMed ID: 33999554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased apoptosis in mononucleated cells but not in CD34+ cells in blastic forms of myelodysplastic syndromes.
    Berger G; Hunault-Berger M; Rachieru P; Fontenay-Roupie M; Baranger L; Ifrah N; Zandecki M
    Hematol J; 2001; 2(2):87-96. PubMed ID: 11424000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: an immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies.
    Thiele J; Braeckel C; Wagner S; Falini B; Dienemann D; Stein H; Fischer R
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):33-9. PubMed ID: 1636247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Megakaryocytopoiesis in bone marrow biopsies of patients with acquired immunodeficiency syndrome (AIDS). An immunohistochemical and morphometric evaluation with special emphasis on myelodysplastic features and precursor cells.
    Thiele J; Titius BR; Quitmann H; Fischer R; Salzberger B; Dienemann D; Stein H
    Pathol Res Pract; 1992 Aug; 188(6):722-8. PubMed ID: 1437834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up.
    Thiele J; Kvasnicka HM; Zerhusen G; Vardiman J; Diehl V; Luebbert M; Schmitt-Graeff A
    Ann Hematol; 2004 Aug; 83(8):513-21. PubMed ID: 15173958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis in myelodysplastic syndromes.
    Pruneri G; Bertolini F; Soligo D; Carboni N; Cortelezzi A; Ferrucci PF; Buffa R; Lambertenghi-Deliliers G; Pezzella F
    Br J Cancer; 1999 Dec; 81(8):1398-401. PubMed ID: 10604739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An immunohistochemical study on megakaryocytes in patients with myelodysplastic syndromes].
    Liu SQ; Liu XF; Song SJ
    Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):288-90. PubMed ID: 7874762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of CD34
    Duarte FB; DE Jesus Dos Santos TE; Barbosa MC; Moura ATG; DE Vasconcelos JPL; Rocha-Filho FD; Coutinho DF; Zalcberg I; Vasconcelos PRL; Garcia YDO; Lemes RPG
    In Vivo; 2019; 33(1):277-280. PubMed ID: 30587636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome.
    Carlsten M; Baumann BC; Simonsson M; Jädersten M; Forsblom AM; Hammarstedt C; Bryceson YT; Ljunggren HG; Hellström-Lindberg E; Malmberg KJ
    Leukemia; 2010 Sep; 24(9):1607-16. PubMed ID: 20613786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. von Willebrand factor is the most reliable immunohistochemical marker for megakaryocytes of myelodysplastic syndrome and chronic myeloproliferative disorders.
    Chuang SS; Jung YC; Li CY
    Am J Clin Pathol; 2000 Apr; 113(4):506-11. PubMed ID: 10761451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.